Stock Yards Bank & Trust CO Apellis Pharmaceuticals, Inc. Transaction History

Stock Yards Bank & Trust CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 02, 2023	SELL	$76.68 - $93.31 $347,513 - $422,880	-4,532 Reduced 47.55%	5,000 $455,000
Q1 2023 May 15, 2023	SELL	$46.59 - $66.96 $78,410 - $112,693	-1,683 Reduced 15.01%	9,532 $629,000
Q4 2022 Feb 02, 2023	BUY	$43.24 - $61.04 $74,156 - $104,683	1,715 Added 18.05%	11,215 $580,000
Q3 2022 Nov 03, 2022	SELL	$44.76 - $69.66 $156,660 - $243,810	-3,500 Reduced 26.92%	9,500 $649,000
Q2 2022 Aug 24, 2022	BUY	$35.07 - $59.21 $455,910 - $769,730	13,000 New	13,000 $588,000

303

112M

3.85M

1.09M

Ticker APLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 109,865,000
Market Cap $3.23B
Description
Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...

Get notified when there are updates to the investment portfolio of Stock Yards Bank & Trust CO, based on Form 13F filings with the SEC.

Stay updated on Stock Yards Bank & Trust CO with notifications on news.